Amgen Inc (AMGN)
264.04
-1.60
(-0.60%)
USD |
NASDAQ |
Apr 17, 16:00
265.08
+1.04
(+0.39%)
Pre-Market: 09:17
Amgen Shareholders Equity (Quarterly): 6.232B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.232B |
September 30, 2023 | 7.656B |
June 30, 2023 | 6.781B |
March 31, 2023 | 5.348B |
December 31, 2022 | 3.661B |
September 30, 2022 | 3.653B |
June 30, 2022 | 2.419B |
March 31, 2022 | 916.00M |
December 31, 2021 | 6.70B |
September 30, 2021 | 8.217B |
June 30, 2021 | 8.247B |
March 31, 2021 | 9.334B |
December 31, 2020 | 9.409B |
September 30, 2020 | 10.96B |
June 30, 2020 | 10.66B |
March 31, 2020 | 9.485B |
December 31, 2019 | 9.673B |
September 30, 2019 | 10.93B |
June 30, 2019 | 10.79B |
March 31, 2019 | 10.83B |
December 31, 2018 | 12.50B |
September 30, 2018 | 14.35B |
June 30, 2018 | 14.91B |
March 31, 2018 | 15.62B |
December 31, 2017 | 25.24B |
Date | Value |
---|---|
September 30, 2017 | 32.23B |
June 30, 2017 | 31.72B |
March 31, 2017 | 30.64B |
December 31, 2016 | 29.88B |
September 30, 2016 | 30.77B |
June 30, 2016 | 30.13B |
March 31, 2016 | 28.68B |
December 31, 2015 | 28.08B |
September 30, 2015 | 27.97B |
June 30, 2015 | 27.48B |
March 31, 2015 | 26.51B |
December 31, 2014 | 25.78B |
September 30, 2014 | 25.32B |
June 30, 2014 | 24.38B |
March 31, 2014 | 22.74B |
December 31, 2013 | 22.10B |
September 30, 2013 | 21.73B |
June 30, 2013 | 20.59B |
March 31, 2013 | 19.49B |
December 31, 2012 | 19.06B |
September 30, 2012 | 19.90B |
June 30, 2012 | 19.24B |
March 31, 2012 | 18.87B |
December 31, 2011 | 19.03B |
September 30, 2011 | 23.55B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
916.00M
Minimum
Mar 2022
10.96B
Maximum
Sep 2020
7.425B
Average
8.217B
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Gilead Sciences Inc | 22.83B |
Johnson & Johnson | 68.77B |
Eli Lilly and Co | 10.77B |
Merck & Co Inc | 37.58B |
Vertex Pharmaceuticals Inc | 17.58B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 97.15B |
Total Liabilities (Quarterly) | 90.92B |
Debt to Equity Ratio | 10.37 |
Current Ratio | 1.649 |
Net Debt Paydown Yield | -3.36% |